Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,823 | -3,012 | -13,600 | -13,357 | -16,440 |
| Depreciation Amortization | N/A | -538 | 153 | 192 | 251 |
| Other Working Capital | 116 | -1,889 | 134 | -2,460 | 2,123 |
| Other Operating Activity | 5,779 | 751 | 2,505 | 2,322 | 591 |
| Operating Cash Flow | $-1,928 | $-4,688 | $-10,808 | $-13,303 | $-13,475 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 1,175 |
| PPE Investments | N/A | N/A | -15 | -73 | -5 |
| Other Investing Activity | 0 | 24 | 0 | -2 | 0 |
| Investing Cash Flow | $N/A | $24 | $-15 | $-75 | $1,170 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,190 | N/A | N/A | 23,915 | 6,096 |
| Other Financing Activity | 0 | 0 | 7 | -40 | -42 |
| Financing Cash Flow | $7,190 | $N/A | $7 | $23,875 | $6,054 |
| Exchange Rate Effect | N/A | N/A | 3 | N/A | N/A |
| Beginning Cash Position | 685 | 5,349 | 16,162 | 5,665 | 11,916 |
| End Cash Position | 5,947 | 685 | 5,349 | 16,162 | 5,665 |
| Net Cash Flow | $5,262 | $-4,664 | $-10,813 | $10,497 | $-6,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,928 | -4,688 | -10,808 | -13,303 | -13,475 |
| Capital Expenditure | N/A | N/A | -15 | -73 | -5 |
| Free Cash Flow | -1,928 | -4,688 | -10,823 | -13,376 | -13,480 |